BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34748351)

  • 1. Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.
    Come JH; Senter TJ; Clark MP; Court JJ; Gale-Day Z; Gu W; Krueger E; Liang J; Morris M; Nanthakumar S; O'Dowd H; Maltais F; Iyer G; Andreassi J; Boucher C; Considine T; Moody CS; Taylor W; Mohanty AK; Huang Y; Zuccola H; Coll J; Bonanno KC; Gagnon KJ; Gan L; Lu F; Gao H; Chakilam A; Engtrakul J; Song B; Crawford D; Doyle E; Kramer T; Vought B; Phillips J; Kemper R; Sanders M; Swett R; Furey B; Winquist R; Bunnage ME; Jackson KL; Charifson PS; Magavi SS
    J Med Chem; 2021 Dec; 64(24):17753-17776. PubMed ID: 34748351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1.
    Boyd MJ; Collier PN; Clark MP; Deng H; Kesavan S; Ronkin SM; Waal N; Wang J; Cao J; Li P; Come J; Davies I; Duffy JP; Cochran JE; Court JJ; Chandupatla K; Jackson KL; Maltais F; O'Dowd H; Boucher C; Considine T; Taylor WP; Gao H; Chakilam A; Engtrakul J; Crawford D; Doyle E; Phillips J; Kemper R; Swett R; Empfield J; Bunnage ME; Charifson PS; Magavi SS
    J Med Chem; 2021 Dec; 64(24):17777-17794. PubMed ID: 34871500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
    Singh J; Khan M; Singh I
    J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy.
    Ofman R; Dijkstra IM; van Roermund CW; Burger N; Turkenburg M; van Cruchten A; van Engen CE; Wanders RJ; Kemp S
    EMBO Mol Med; 2010 Mar; 2(3):90-7. PubMed ID: 20166112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
    Singh J; Khan M; Singh I
    Biochim Biophys Acta; 2013 Apr; 1831(4):747-58. PubMed ID: 23318275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.
    Engelen M; Schackmann MJ; Ofman R; Sanders RJ; Dijkstra IM; Houten SM; Fourcade S; Pujol A; Poll-The BT; Wanders RJ; Kemp S
    J Inherit Metab Dis; 2012 Nov; 35(6):1137-45. PubMed ID: 22447153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis.
    Schackmann MJ; Ofman R; Dijkstra IM; Wanders RJ; Kemp S
    Biochim Biophys Acta; 2015 Feb; 1851(2):231-7. PubMed ID: 25499606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational insight into structural basis of human ELOVL1 inhibition.
    Siddiqui AJ; Kumar V; Jahan S; Alshahrani MM; Al Awadh AA; Siddiqui MA; Hamadou WS; Abdelgadir A; Saxena J; Badraoui R; Snoussi M; Adnan M
    Comput Biol Med; 2023 May; 157():106786. PubMed ID: 36924735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid.
    Sassa T; Wakashima T; Ohno Y; Kihara A
    J Lipid Res; 2014 Mar; 55(3):524-30. PubMed ID: 24489110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.
    Raas Q; van de Beek MC; Forss-Petter S; Dijkstra IM; Deschiffart A; Freshner BC; Stevenson TJ; Jaspers YR; Nagtzaam L; Wanders RJ; van Weeghel M; Engelen-Lee JY; Engelen M; Eichler F; Berger J; Bonkowsky JL; Kemp S
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
    Morita M
    Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
    Kruska N; Schönfeld P; Pujol A; Reiser G
    Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo mutation in
    Mueller N; Sassa T; Morales-Gonzalez S; Schneider J; Salchow DJ; Seelow D; Knierim E; Stenzel W; Kihara A; Schuelke M
    J Med Genet; 2019 Mar; 56(3):164-175. PubMed ID: 30487246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bezafibrate for X-linked adrenoleukodystrophy.
    Engelen M; Tran L; Ofman R; Brennecke J; Moser AB; Dijkstra IM; Wanders RJ; Poll-The BT; Kemp S
    PLoS One; 2012; 7(7):e41013. PubMed ID: 22911730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy.
    Khan M; Pahan K; Singh AK; Singh I
    J Neurochem; 1998 Jul; 71(1):78-87. PubMed ID: 9648853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase.
    Morita M; Kawamichi M; Shimura Y; Kawaguchi K; Watanabe S; Imanaka T
    Metab Brain Dis; 2015 Dec; 30(6):1359-67. PubMed ID: 26108493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical aspects of X-linked adrenoleukodystrophy.
    Kemp S; Wanders R
    Brain Pathol; 2010 Jul; 20(4):831-7. PubMed ID: 20626744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.